Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)

    Support basic research to uncover biological/genetic causes of cancer health disparities through innovative studies, methodologies, and data analysis.

    Browse similar grants
    Cancer Research Grants 2026Public Health Research Grants 2026Research Grants Due This Month
    OverviewSimilar Grants
    OverviewSimilar Grants

    Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

    Support for innovative research to improve cancer control through behavior modification, screening, and understanding etiologic factors, with the aim of advancing population-based cancer studies.

    HHS-NIH11Due Nov 16, 2026· 11d

    Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

    This grant supports researchers in analyzing existing data to understand cancer risk and related outcomes, aiming to address key scientific questions in cancer research.

    HHS-NIH11Due Nov 16, 2026· 11d$275,000

    Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)

    NIH supports research on the causes, biological mechanisms, and early detection of non-hereditary cancers in adults ages 18–49 to inform prevention and control strategies.

    HHS-NIH11Due Feb 8, 2027$2,500,000

    Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

    This grant funds projects to further develop and validate innovative technologies that advance cancer research or clinical care, focusing on technical improvements and rigorous validation for broad adoption.

    HHS-NIH11Forecasted Jun 4, 2027$300,000Forecasted

    Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

    This grant funds early-stage, highly innovative technology development projects to improve cancer research or clinical care, focusing on proof-of-concept studies with high potential impact in cancer-related fields.

    HHS-NIH11Forecasted Jun 4, 2027$150,000Forecasted